These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1329330)

  • 21. Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge.
    Emini EA; Schleif WA; Silberklang M; Lehman D; Ellis RW
    J Med Virol; 1989 Feb; 27(2):120-3. PubMed ID: 2537882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine.
    Jackman WT; Mann KA; Hoffmann HJ; Spaete RR
    Vaccine; 1999 Feb; 17(7-8):660-8. PubMed ID: 10067671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo.
    Thorley-Lawson DA; Poodry CA
    J Virol; 1982 Aug; 43(2):730-6. PubMed ID: 6287039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the endogenously expressed Epstein-Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV-neutralizing epitope and affects gp350-specific ADCC.
    Khyatti M; Ahmad A; Blagdon M; Frade R; Menezes J
    J Leukoc Biol; 1998 Aug; 64(2):192-7. PubMed ID: 9715258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200).
    Hummel M; Thorley-Lawson D; Kieff E
    J Virol; 1984 Feb; 49(2):413-7. PubMed ID: 6319741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA.
    Shimizu N; Yamaki M; Sakuma S; Ono Y; Takada K
    Int J Cancer; 1988 May; 41(5):744-51. PubMed ID: 2835324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
    Thorley-Lawson DA; Geilinger K
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of vaccinia surface antigen expressed by recombinant baculovirus.
    Morikawa S; Ueda Y
    Virology; 1993 Apr; 193(2):753-61. PubMed ID: 8460484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and analysis of the Epstein-Barr virus glycoprotein 350 genes.
    Chang SH; Kim SH; Lee WK; Kim HJ; Choi SH; Park JH; Jang HS; Chung GH; Kwon TH; Kim DH; Yang MS; Jang YS
    Mol Cells; 1998 Oct; 8(5):585-93. PubMed ID: 9856346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic peptides to identify antigenic determinants on Epstein-Barr virus gp350/220.
    Bertoni G; Kostyal DA; Reisert PS; Humphreys RE; Sairenji T
    Intervirology; 1990; 31(5):290-4. PubMed ID: 1703134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
    Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.
    Xu J; Ahmad A; Blagdon M; D'Addario M; Jones JF; Dolcetti R; Vaccher E; Prasad U; Menezes J
    Int J Cancer; 1998 Oct; 79(5):481-6. PubMed ID: 9761116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.
    Tanner J; Whang Y; Sample J; Sears A; Kieff E
    J Virol; 1988 Dec; 62(12):4452-64. PubMed ID: 2460635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen.
    Durda PJ; Sullivan M; Kieff E; Pearson GR; Rabin H
    Intervirology; 1993; 36(1):11-9. PubMed ID: 8225907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncated versions of the two major Epstein-Barr viral glycoproteins (gp250/350) are secreted by recombinant Chinese hamster ovary cells.
    Motz M; Deby G; Wolf H
    Gene; 1987; 58(1):149-54. PubMed ID: 2826297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
    Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
    J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties.
    Reischl U; Gerdes C; Motz M; Wolf H
    J Virol Methods; 1996 Mar; 57(1):71-85. PubMed ID: 8919825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus.
    Stewart JP; Hampson IN; Heinrich HW; Mackett M; Arrand JR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1231-7. PubMed ID: 2543776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.